{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:00:41Z","timestamp":1788397241507,"version":"build-2803163510"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study aimed to evaluate the incidence and predict the risk factors of lymph node (LN) metastasis among patients with grossly apparent early-stage epithelial ovarian cancer (EOC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We retrospectively reviewed the clinicopathologic data and follow-up information of 266 patients who underwent LN dissection for apparent early-stage EOC between January 2018 and September 2022 at the Obstetrics and Gynecology Hospital of Fudan University.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among 266 patients, 44 (16.5%) showed LN metastasis, of which 65.9% and 59.1% presented in the pelvic region and para-aortic region, respectively. Univariate analysis revealed higher LN positivity in patients with high-grade serous carcinoma (HGSC), preoperative imaging suggestive of LN metastasis, bilateral adnexal involvement, lymphovascular space invasion (LVSI), positive peritoneal cytology, and clinical stage IIA. LN metastases were identified in 7.9%, 10.2%, and 39.7% of clinical stage IA\/B, IC, and IIA disease cases, respectively. Multivariate analysis confirmed significantly higher LN positivity rates in patients with HGSC, LVSI, and clinical stage IIA. In clinical stage IIA EOC, the 3-year progression-free survival (PFS) rates were 65.8% and 77.4% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.360) for LN-negative and LN-positive groups, respectively. In clinical stage I EOC, the 3-year PFS rates were 93.5% and 59.4% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) for LN-negative and LN-positive groups, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>High-grade serous histology, LVSI, and clinical stage IIA disease are predictive factors for LN involvement in early-stage EOC. In addition, LN metastasis appears to be associated with worse PFS in clinical stage I EOC compared with clinical stage IIA EOC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_2489_23","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T11:49:45Z","timestamp":1724932185000},"page":"1300-1305","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Lymph node metastasis in grossly apparent early-stage epithelial ovarian cancer: A retrospective clinical study at a tertiary institute"],"prefix":"10.4103","volume":"20","author":[{"given":"Menghan","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Jinshan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"Cancer J Clin"},{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/cells8050505","article-title":"Current status of patient-derived ovarian cancer models","volume":"8","author":"Maru","year":"2019","journal-title":"Cells"},{"issue":"Suppl 2","key":"R3-20241021","doi-asserted-by":"crossref","first-page":"S857","DOI":"10.4103\/jcrt.jcrt_1426_22","article-title":"Ovarian cancer:A report from population-based cancer registry at central rural India","volume":"19","author":"Gangane","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/IGC.0000000000000514","article-title":"Understanding lymphatic drainage pathways of the ovaries to predict sites for sentinel nodes in ovarian cancer","volume":"25","author":"Kleppe","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"682348","DOI":"10.3389\/fsurg.2021.682348","article-title":"Impact of lymphadenectomy on outcomes of early-stage ovarian cancer:A systematic review and meta-analysis","volume":"8","author":"Yao","year":"2021","journal-title":"Front Surg"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer:Pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann Oncol"},{"issue":"Suppl 24","key":"R7-20241021","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1002\/cncr.32514","article-title":"How to manage lymph nodes in ovarian cancer","volume":"125","author":"Harter","year":"2019","journal-title":"Cancer"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"610","DOI":"10.4103\/jcrt.jcrt_109_21","article-title":"Factors that contribute to the recurrence of mucinous ovarian cancer:Monocenter retrospective evaluation","volume":"19","author":"Birge","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2017.07.139","article-title":"Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer:A predictors- and nomogram-based analyses","volume":"147","author":"Bogani","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1159\/000488082","article-title":"Evaluation of factors affecting lymph node metastasis in clinical stage I-II epithelial ovarian cancer","volume":"41","author":"Erdem","year":"2018","journal-title":"Oncol Res Treat"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00404-013-3078-3","article-title":"Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary:Review of a single-institution experience","volume":"289","author":"Ulker","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2022.01.013","article-title":"Lymphovascular space invasion in endometrial carcinoma:A prognostic factor independent from molecular signature","volume":"165","author":"Raffone","year":"2022","journal-title":"Gynecol Oncol"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ygyno.2019.09.016","article-title":"LVSI positive and NX in early endometrial cancer:Surgical restaging (and no further treatment if N0), or adjuvant ERT?","volume":"156","author":"Harris","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jso.24801","article-title":"Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma","volume":"117","author":"Matsuo","year":"2018","journal-title":"J Surg Oncol"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jso.24801","article-title":"Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma","volume":"117","author":"Matsuo","year":"2018","journal-title":"J Surg Oncol"},{"key":"R17-20241021","doi-asserted-by":"crossref","DOI":"10.4103\/jcrt.jcrt_656_21","article-title":"MRI assessment of ovarian masses and correlating with CA-125","author":"Ranganath","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2009.10.059","article-title":"Diagnosis and staging of primary ovarian cancer:Correlation between PET\/CT, Doppler US, and CT or MRI","volume":"116","author":"Nam","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R19-20241021","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bpobgyn.2016.10.001","article-title":"Surgical treatment of early-stage ovarian cancer","volume":"41","author":"Trimbos","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R20-20241021","first-page":"232","article-title":"Lymph node involvement in clinically apparent early ovarian cancer:A prospective study","volume":"38","author":"Khouly","year":"2017","journal-title":"Eur J Gynaecol Oncol"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/1471-0528.14226","article-title":"Surgical lymph node assessment in mucinous ovarian carcinoma staging:A systematic review and meta-analysis","volume":"124","author":"Hoogendam","year":"2017","journal-title":"BJOG"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.3802\/jgo.2021.32.e40","article-title":"The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer","volume":"32","author":"Deng","year":"2021","journal-title":"J Gynecol Oncol"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.3802\/jgo.2020.31.e67","article-title":"Lymphadenectomy for primary ovarian cancer:A systematic review and meta-analysis","volume":"31","author":"Chiyoda","year":"2020","journal-title":"J Gynecol Oncol"},{"key":"R24-20241021","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ygyno.2020.10.028","article-title":"Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?","volume":"160","author":"Bizzarri","year":"2021","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2489_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:42:54Z","timestamp":1787067774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2489_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2489_23","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"2023-11-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}